Biomoda makes Maria Zannes CEO
This article was originally published in Clinica
Maria Zannes has been appointed CEO of Biomoda, a company specialising in cancer diagnostics. Ms Zannes is also the firm’s chairman and has previously worked as a consultant for private clients in the medical, energy and environmental industries. She replaces John Cousins, who will remain Biomoda’s president and CFO. The Albuquerque, New Mexico-based company is currently seeking FDA approval for its CyPath diagnostic assay, which is designed to detect lung cancer at an early stage. Biomoda also has tests for cervical, breast, colorectal, bladder and oral cancers in the pipeline.